Matthias Schröter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Matthias Schröter has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Rainer Laufs
7 shared publicationsHeinz-Hubert Feucht
6 shared publicationsBernhard Zöllner
Institut für Medizinische Mikrobiologie und Immunologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
3 shared publicationsPeter Schäfer
Institut für Medizinische Mikrobiologie und Immunologie, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany
3 shared publicationsAngelika Speicher
Institut für Infektionsmedizin, Universitätsklinikum Hamburg-Eppendorf, 20246 Hamburg,1 Institut für Hygiene und Umwelt, Abteilung Mikrobiologischer Verbraucherschutz, National Reference Centre for Enteric Pathogens (NRZE), 20539 Hamburg,2 Heublink 29, 22391 Hamburg, Germany3
1 shared publicationBernhard Zoellner
1 shared publication
Latest Publications
- 24 May 2005
- Published by S. Karger AG in Intervirology
- Vol. 48 (4) , 213-215
Prolonged Time until Seroconversion among Hemodialysis Patients: The Need for HCV PCR
Objective: Patients on maintenance hemodialysis are known to have an elevated risk of acquiring hepatitis C virus (HCV) infection. Therefore, a reliable diagnosis of HCV infection is essential in order to prevent the spread of the disease in dialysis units. However, whether PCR examination is dispensable in hemodialysis patients has been debated. Methods: From 1995 to 2002, serum samples from all hemodialysis patients at our hospital (n = 1,774) were screened by serological assays and by polymerase chain reaction (PCR). Results: In 25 of these patients acute HCV infection was observed and in 11 patients HCV seroconversion was delayed for 3–16 months. During this time the infection was exclusively detectable by PCR. Conclusion: Despite the growing demand for cost-effectiveness in the health system, HCV PCR examination must remain an essential part of the routine screening in hemodialysis patients.
- 24 May 2005
- Published by S. Karger AG in Intervirology
- Vol. 48 (4) , 213-215
Prolonged Time until Seroconversion among Hemodialysis Patients: The Need for HCV PCR
Objective: Patients on maintenance hemodialysis are known to have an elevated risk of acquiring hepatitis C virus (HCV) infection. Therefore, a reliable diagnosis of HCV infection is essential in order to prevent the spread of the disease in dialysis units. However, whether PCR examination is dispensable in hemodialysis patients has been debated. Methods: From 1995 to 2002, serum samples from all hemodialysis patients at our hospital (n = 1,774) were screened by serological assays and by polymerase chain reaction (PCR). Results: In 25 of these patients acute HCV infection was observed and in 11 patients HCV seroconversion was delayed for 3–16 months. During this time the infection was exclusively detectable by PCR. Conclusion: Despite the growing demand for cost-effectiveness in the health system, HCV PCR examination must remain an essential part of the routine screening in hemodialysis patients.
- 1 January 2004
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 70 (1) , 613-615
Pet Snakes as a Reservoir for Salmonella enterica subsp. diarizonae (Serogroup IIIb): a Prospective Study
Reptile-associated Salmonella infections are an increasing problem for humans. We have prospectively screened two breeding groups of 16 pet snakes for colonization with Salmonella species. Various serovars of S. enterica subsp. diarizonae were found in 81% of the snakes. To avoid transmission, strict hygienic precautions should be applied when reptiles are handled.
- 1 January 2004
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 70 (1) , 613-615
Pet Snakes as a Reservoir for Salmonella enterica subsp. diarizonae (Serogroup IIIb): a Prospective Study
Reptile-associated Salmonella infections are an increasing problem for humans. We have prospectively screened two breeding groups of 16 pet snakes for colonization with Salmonella species. Various serovars of S. enterica subsp. diarizonae were found in 81% of the snakes. To avoid transmission, strict hygienic precautions should be applied when reptiles are handled.
- 1 May 2003
- Published by Elsevier in Journal of Clinical Virology
- Vol. 27 (1) , 69-73
A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance
- 1 May 2003
- Published by Elsevier in Journal of Clinical Virology
- Vol. 27 (1) , 69-73
A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance
- 10 December 2002
- Published by Elsevier in Journal of Clinical Virology
- Vol. 27 (2) , 200-204
Multiple infections with different HCV genotypes: prevalence and clinical impact
- 10 December 2002
- Published by Elsevier in Journal of Clinical Virology
- Vol. 27 (2) , 200-204
Multiple infections with different HCV genotypes: prevalence and clinical impact
- 3 October 2001
- Published by Elsevier in Journal of Clinical Virology
- Vol. 23 (1-2) , 57-63
Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays
- 3 October 2001
- Published by Elsevier in Journal of Clinical Virology
- Vol. 23 (1-2) , 57-63
Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays
- Open Access
- 1 February 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (2) , 765-768
Quantitative Detection of Hepatitis C Virus RNA by Light Cycler PCR and Comparison with Two Different PCR Assays
The new Light Cycler technology was adapted to the detection of hepatitis C virus (HCV) RNA in clinical samples. Sera from 81 patients were tested by Light Cycler PCR, AMPLICOR HCV Monitor assay, and in-house PCR. Our data demonstrate that Light Cycler is a fast and reliable method for the detection and quantitation of HCV RNA.
- 1 February 2001
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 39 (2) , 765-768
Open AccessQuantitative Detection of Hepatitis C Virus RNA by Light Cycler PCR and Comparison with Two Different PCR Assays
The new Light Cycler technology was adapted to the detection of hepatitis C virus (HCV) RNA in clinical samples. Sera from 81 patients were tested by Light Cycler PCR, AMPLICOR HCV Monitor assay, and in-house PCR. Our data demonstrate that Light Cycler is a fast and reliable method for the detection and quantitation of HCV RNA.
- 1 August 1999
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 37 (8) , 2576-2580
Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay
Serological determination of hepatitis C virus (HCV) subtypes has been hampered by the lack of suitable assays. Therefore, a recombinant immunoblot assay has been established for serological differentiation of HCV subtypes 1a, 1b, 2a, 2b, 3a, and 4a. It consists of recombinant HCV proteins from the NS-4 region propagated in Escherichia coli . To confirm the serotyping assay results, the results were compared with those obtained by nucleotide sequencing of the NS-5 region. Sera from 157 patients with chronic HCV infection were examined by this assay, and specific antibodies could be detected in 86% ( n = 135) of them. The HCV genotype was determined correctly in all but one sample, and the subtypes determined by the serotyping assay corresponded to the HCV subtypes detected by nucleotide sequencing for 95% ( n = 128) of the samples. These data indicate that HCV subtypes can be distinguished serologically. The assay that is described provides an easier means of identification of infection with different HCV subtypes for wider clinical and epidemiological applications.
- 1 August 1999
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 37 (8) , 2576-2580
Serological Determination of Hepatitis C Virus Subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a Recombinant Immunoblot Assay
Serological determination of hepatitis C virus (HCV) subtypes has been hampered by the lack of suitable assays. Therefore, a recombinant immunoblot assay has been established for serological differentiation of HCV subtypes 1a, 1b, 2a, 2b, 3a, and 4a. It consists of recombinant HCV proteins from the NS-4 region propagated in Escherichia coli . To confirm the serotyping assay results, the results were compared with those obtained by nucleotide sequencing of the NS-5 region. Sera from 157 patients with chronic HCV infection were examined by this assay, and specific antibodies could be detected in 86% ( n = 135) of them. The HCV genotype was determined correctly in all but one sample, and the subtypes determined by the serotyping assay corresponded to the HCV subtypes detected by nucleotide sequencing for 95% ( n = 128) of the samples. These data indicate that HCV subtypes can be distinguished serologically. The assay that is described provides an easier means of identification of infection with different HCV subtypes for wider clinical and epidemiological applications.